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 In its launch issue in October 2004,  PLoS Medicine signaled a strong interest in creating a journal that 
went beyond a biological view of health 
to incorporate socioeconomic, ethical, 
and cultural dimensions. For example, 
that ﬁ rst issue contained a policy paper 
on how the health community should 
respond to violent political conﬂ ict [1], 
a debate on whether health workers 
should screen all women for domestic 
violence [2], and a study on the global 
distribution of risk factors for disease 
[3]. 
 Two years on, our October 2006 
issue takes our interest even further. 
It contains a special collection of ten 
magazine articles and ﬁ ve research 
papers devoted entirely to social 
medicine. We are delighted that the 
collection features many of the leaders 
in the ﬁ eld, including the renowned 
medical anthropologists Paul Farmer 
and Arthur Kleinman, the former 
United States Surgeon General David 
Satcher, and the Harvard professor of 
social medicine and psychiatry Leon 
Eisenberg.
 Most of our readers have welcomed 
our inclusive view of what a medical 
journal should highlight. Some, 
however, have been critical, suggesting 
that we should publish “less soft stuff” 
and more “hard science.” These critics 
might argue that in this era of stem 
cell research and the human genome 
project, of molecular medicine and 
DNA microarray technology, the 
notion of social medicine seems 
irrelevant and outmoded. 
 But the ultimate role of a medical 
journal is surely to contribute to 
health improvement, and that means 
looking not just at molecules but at 
the social structures that contribute 
to illness. The stark fact is that most 
disease on the planet is attributable 
to the social conditions in which 
people live and work [4]. The socially 
disadvantaged have less access to 
health services, and get sicker and die 
earlier than the privileged. Despite 
impressive technological advances in 
medicine, global health inequalities are 
worsening. 
 “All medicine is inescapably social,” 
said Leon Eisenberg [5], and we 
entirely agree. Take, for example, the 
announcement of the sequencing 
of the human genome, which the 
BBC predicted would mean we 
could “banish inherited disorders, 
screen people for their vulnerability 
to diseases, tailor treatment to an 
individual’s genetic make-up, create 
thousands of new drugs and extend 
human lifespan” [6]. In time, perhaps 
these predictions will be partly or fully 
realized. What is certain, though, is that 
the human genome project has also 
opened up an immediate Pandora’s 
Box of complex ethical, legal, and 
social issues. These issues include 
ensuring equity in patients’ access to 
the fruits of the project and balancing 
the beneﬁ ts, risks, and economic costs 
of genetic screening. Even the human 
genome is “inescapably social.”
 And so, to complement the papers 
on molecular medicine that we have 
published over the last two years—such 
as papers on genetic mutations that 
confer resistance to cancer drugs 
[7,8] or on differentiation of insulin-
producing cells from human neural 
progenitor cells [9]—we have also 
dedicated space in the journal to 
considering the large-scale social forces 
that give rise to human disease and 
affect its distribution around the globe. 
These include economics, politics, legal 
institutions, and power structures.
 Throughout our special collection, 
one pioneer in understanding these 
large-scale social forces is repeatedly 
acknowledged—Rudolf Virchow. 
In his 1848 medical report of an 
outbreak of typhus in Silesia, Virchow 
concluded that poverty and living 
conditions, not biology, were the 
prime causes of the epidemic [10]. 
While an understanding of these large-
scale forces remains social medicine’s 
base and one of its most important 
tasks, this special collection shows 
the ways in which ﬁ ner-grained social 
forces have an equally important 
effect on health. The different levels 
at which social forces operate can be 
considered as four primary domains, 
beginning in the clinical encounter 
and opening outward to society and 
the globe.  
 The ﬁ rst domain, then, is made up 
of the cultural and social aspects of 
the relationship between patients and 
health professionals. This relationship 
is a social negotiation affected by 
beliefs, practices, interests, and power 
dynamics. Communication within 
this relationship can have a powerful 
impact upon health outcomes. The 
inﬂ uence of this relationship upon 
health is not limited to Western, 
allopathic, biomedical systems but is 
equally as important in other medical 
systems throughout the world [11]. 
 The second domain involves 
patients’ beliefs, practices, and 
experiences. Patients’ experiences 
of and responses to suffering are not 
conﬁ ned to the clinical encounter 
and vary dramatically among different 
populations. Understanding the 
speciﬁ cs of people’s everyday lives is 
essential to engaging with them and 
their illnesses [12,13].
 The third domain is the culture of 
medicine itself. Health professionals 
and institutions have their own 
cultures that also go beyond clinical 
interactions. Health systems and 
health research both contain agendas, 
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prejudices, and beliefs that can lead 
to certain perspectives being favored 
as the most legitimate. Understanding 
the culture of medicine is essential to 
understanding health professionals’ 
attitudes toward illness, patients, and 
treatments [14–16].
 The ﬁ nal domain brings us, full 
circle, back to Virchow and the large-
scale forces that shape health, which 
have become known as the social 
determinants of disease. The 15 papers 
in the special collection each relate to 
at least one of these four domains, as 
shown in Table 1. 
 In their compelling policy paper for 
this special collection, Paul Farmer and 
colleagues argue that while the search 
for the molecular basis of disease has 
been enormously fruitful, there has at 
the same time been a “desocialization” 
of scientiﬁ c inquiry. In other words, 
they say, there has been “a tendency 
to ask only biological questions about 
what are in fact  biosocial phenomena” 
[17]. We hope that our special 
collection helps to “resocialize” our 
understanding of disease distributions 
and outcomes.  
 Table 1.  The Four Domains of Social Medicine in the Special Collection 
Domain of Social 
Medicine
Authors Title and Reference
 Relationship between 
patients and health 
professionals 
Arthur Kleinman and 
Peter Benson 
Anthropology in the clinic: The problem of cultural 
competency and how to ﬁ x it. PLoS Med 3(10): 
e294.
 Patients’ beliefs, practices, 
and experiences 
Philippe Bourgois, 
Alexis Martinez, Alex Kral, 
Brian R. Edlin, Jeff Schonberg, 
and Dan Ciccarone
Reinterpreting ethnic patterns among white and 
African American men who inject heroin: A social 
science of medicine approach. PLoS Med 3(10): 
e452.
Tarif Bakdash and 
Nancy Scheper-Hughes 
Is it ethical for patients with renal disease to 
purchase kidneys from the world’s poor? PLoS Med 
3(10): e349.
 The culture of medicine Dorothy Porter How did social medicine evolve, and where is it 
heading? PLoS Med 3(10): e399.
Scott Stonington and 
Pinit Ratanakul 
Is there a global bioethics? End-of life in Thailand 
and the case for local difference. PLoS Med 3(10): 
e439.
Maya L. Ponte Insights into the management of emerging 
infections: Regulating variant Creutzfeldt-Jakob 
Disease transfusion risk in the UK and US. PLoS 
Med 3(10): e342.
Rafael Campo “Anecdotal evidence”: Why narratives matter to 
medical practice. PLoS Med 3(10): e423.
Rajesh Gupta Why should medical students care about health 
policy? PLoS Med 3(10): e199.
Nelson Martins, Paul M. 
Kelly, Jocelyn A. Grace, and 
Anthony B. Zwi 
Reconstructing tuberculosis services after major 
conﬂ ict: Experiences and lessons learned in East 
Timor. PLoS Med 3(10): e383.
 The social determinants 
of disease 
Timothy H. Holtz, Seth M. 
Holmes, Scott Stonington, 
and Leon Eisenberg 
Health is still social: Contemporary examples in the 
age of the genome. PLoS Med 3(10): e419.
David Satcher Ethnic disparities in health: The public’s role in 
working for equality. PLoS Med 3(10): e405.
Paul E. Farmer, Bruce Nizeye, 
Sara Stulac, and Salmaan 
Keshavjee
Structural violence and clinical medicine. PLoS 
Med 3(10): e449.
Seth M. Holmes An ethnographic study of the social context of 
migrant health in the United States. PLoS Med 
3(10): e448.
Colin Butler and Sharon Friel Time to regenerate: Ecosystems and health 
promotion. PLoS Med 3(10): e394.
S. V. Subramanian, 
George Davey Smith, and 
Malavika Subramanyam
Indigenous health and socioeconomic status in 
India. PLoS Med 3(10): e421.
 DOI: 10.1371/journal.pmed.0030445.t001 
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